Resignation of Non Executive Director Will Delaat
Release Date: 05/08/2022 8:32am
Pharmaceutical research company Pharmaxis (ASX: PXS) today announced that its long serving non-executive director Will Delaat AM has resigned from the Board due to ill health.
Mr Delaat’s resignation, effective from 4 August marks the end of his significant contribution to the evolution of the Pharmaxis business. He joined the Board in June 2008 and has served as a non-executive director over a period of substantial change which has seen Pharmaxis repositioned as a clinical stage drug development company, building its platform of drugs for inflammatory and fibrotic diseases. He has served on the Remuneration and Nomination Committees and as Chair of the Audit and Risk Committee.
Categories: News and Media